SeeSAR as a tool for compound prioritization

webinar

Thu, 05 Mar 2015, 19:00 CET (Berlin)

Dr. Carsten Detering, BioSolveIT GmbH, St. Augustin, Germany

SeeSAR as a tool for compound prioritization

With today’s pharma projects under increased pressure, it is necessary to put more emphasis on how the medicinal chemists can be helped achieve their goals faster. Given the vast amount of compounds medicinal chemists have to deal with, it is difficult to synthesize them all or make an informed decision, respectively, which ones to further pursue.
SeeSAR is a tool for the medicinal chemist which lets them sketch out ideas for compound modifications and which tells them right away if the modifications made are beneficial for the affinity. Intuitive visual representation suggests where to optimize, and why. SeeSAR is a tool for 21st century research.

  • ROI after only 5 syntheses spared by SeeSAR
  • easiest user interface in the industry
  • interactive usage, fast and intuitive results

Who should attend?
Computational and medicinal chemists, crystallographers, managers, everybody interested in modern drug discovery.

Why should you attend?
If you want to learn about software tools of the 21st century, this webinar is a must.

Current news

What's So Special About The 'Activity Spotter'? Detailed Insights Into SeeSAR's New Mode
April 29, 2026 10:22 CEST
SeeSAR’s Activity Spotter Mode is designed to dismantle the barrier of raw data and actionable SAR. It helps to answer the most relevant fields in hit-to-lead and lead optimization campaigns: 3D SAR and pharmacophore modeling. Which structural features in my molecule set are associated with activity? Which ones are linked...
Read on
Tool of the Month - FlexX
April 29, 2026 08:53 CEST
Spring is Molecular Docking Season The bread and butter of computational chemistry: predicting potential binding modes, which serves as a crucial foundation for SAR analysis and design decisions, is being made available to everyone this month with the proprietary docking tool FlexX. Validated by over 10,000 citations of its original...
Read on
The 95 Billion Update: Access the REAL Space
April 9, 2026 13:57 CEST
The latest update of Enamine’s REAL Space brings a new expansion, now featuring over 94.5 billion accessible, drug-like products, approaching the 100 billion mark. Built from 173 curated reaction protocols and 202,620 in-stock reagents and building blocks based on Enamine’s in-house knowledge, this version further enhances the world’s largest commercially...
Read on